UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ACLX — Arcellx, Inc.
CIK 861177
NEW YORK, NY
Position in ACLX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$6,577,919
-$3,921,561 QoQ
Shares Held
57,289
-64.4% QoQ
Ownership
0.098%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority
Sole 34%
Shared 0%
None 66%
Common Shares in ACLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. ACLX ranks #56 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in ACLX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,577,919 | 57,289 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $10,499,480 | 161,035 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,844,603 | 168,631 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,589,256 | 267,111 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $17,367,990 | 264,756 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $20,505,675 | 267,384 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $23,621,219 | 282,855 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $17,129,979 | 310,382 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $18,459,264 | 265,410 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $7,222,547 | 130,136 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,659,075 | 185,593 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $524,892 | 16,600 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $511,446 | 16,600 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $424,426 | 13,700 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||